Concepedia

Lina Han

LH

Statistics

Publications

34

Citations

3.8K

H-Index

22

Active since

2009

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Harbin Medical University

First Affiliated Hospital of Harbin Medical University

Seoul National University

AbbVie (United States)

Lina Han is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2009–2024

34

Publications

34

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova et al. · Nature Medicine · 2018 · 951 citations · Full text

, , +14

Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

Rongqing Pan, Leah J. Hogdal, Juliana M. Benito et al. · Cancer Discovery · 2013 · 735 citations · Full text

, , +17

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele et al. · Blood · 2021 · 718 citations · Full text

, , +17

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

Qi Zhang, Bridget Riley‐Gillis, Lina Han et al. · Signal Transduction and Targeted Therapy · 2022 · 181 citations · Full text

, , +17

Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis

Aleksandra Rizo, Sandra Olthof, Lina Han et al. · Blood · 2009 · 178 citations · Full text

, , +8

1–5 of 34